Bender Shawn B, de Beer Vincent J, Tharp Darla L, van Deel Elza D, Bowles Douglas K, Duncker Dirk J, Laughlin M Harold, Merkus Daphne
Experimental Cardiology, Thoraxcenter, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands.
J Physiol. 2014 Apr 15;592(8):1757-69. doi: 10.1113/jphysiol.2013.267351. Epub 2014 Jan 13.
Vascular dysfunction has been associated with familial hypercholesterolaemia (FH), a severe form of hyperlipidaemia. We recently demonstrated that swine with FH exhibit reduced exercise-induced systemic, but not pulmonary, vasodilatation involving reduced nitric oxide (NO) bioavailability. Since NO normally limits endothelin (ET) action, we examined the hypothesis that reduced systemic vasodilatation during exercise in FH swine results from increased ET-mediated vasoconstriction. Systemic and pulmonary vascular responses to exercise were examined in chronically instrumented normal and FH swine in the absence and presence of the ETA/B receptor antagonist tezosentan. Intrinsic reactivity to ET was further assessed in skeletal muscle arterioles. FH swine exhibited ∼9-fold elevation in total plasma cholesterol versus normal swine. Similar to our recent findings, systemic, not pulmonary, vasodilatation during exercise was reduced in FH swine. Blockade of ET receptors caused marked systemic vasodilatation at rest and during exercise in normal swine that was significantly reduced in FH swine. The reduced role of ET in FH swine in vivo was not the result of decreased arteriolar ET responsiveness, as responsiveness was increased in isolated arterioles. Smooth muscle ET receptor protein content was unaltered by FH. However, circulating plasma ET levels were reduced in FH swine. ET receptor antagonism caused pulmonary vasodilatation at rest and during exercise in normal, but not FH, swine. Therefore, contrary to our hypothesis, FH swine exhibit a generalised reduction in the role of ET in regulating vascular tone in vivo probably resulting from reduced ET production. This may represent a unique vascular consequence of severe familial hypercholesterolaemia.
血管功能障碍与家族性高胆固醇血症(FH)有关,后者是一种严重的高脂血症形式。我们最近证明,患有FH的猪运动诱导的全身血管舒张(而非肺血管舒张)减弱,这涉及一氧化氮(NO)生物利用度降低。由于NO通常会限制内皮素(ET)的作用,我们检验了这样一种假说,即FH猪运动期间全身血管舒张减弱是由ET介导的血管收缩增加所致。在植入长期监测仪器的正常猪和FH猪中,在使用和不使用ETA/B受体拮抗剂替唑生坦的情况下,检测了运动对全身和肺血管的反应。进一步评估了骨骼肌小动脉对ET的内在反应性。与正常猪相比,FH猪的血浆总胆固醇升高了约9倍。与我们最近的研究结果相似,FH猪运动期间的全身血管舒张(而非肺血管舒张)减弱。阻断ET受体在正常猪休息和运动期间引起明显的全身血管舒张,而在FH猪中这种舒张作用明显减弱。ET在FH猪体内作用减弱并非小动脉ET反应性降低所致,因为在分离的小动脉中反应性增强。FH并未改变平滑肌ET受体蛋白含量。然而,FH猪的循环血浆ET水平降低。ET受体拮抗在正常猪而非FH猪休息和运动期间引起肺血管舒张。因此,与我们的假说相反,FH猪体内ET在调节血管张力方面的作用普遍减弱,这可能是ET生成减少所致。这可能代表了严重家族性高胆固醇血症独特的血管后果。